Advertisement

Topics

F-star Company Profile

15:08 EST 18th December 2018 | BioPortfolio

F-star is a biopharmaceutical company developing novel bispecific antibody products to improve the treatment of cancer.

F-star is a leader in the development of novel bispecific antibodies

F-star is an oncology-focused biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve the standard of care for patients.

Our Modular Antibody Technology™ allows us to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. It combines the power of our Fcab™ technology with traditional antibodies to identify the most appropriate target combinations, thus providing the opportunity to deliver products with the greatest therapeutic advantage to patients.

Developing genuine bispecific monoclonal antibodies

Our technology capitalizes on decades of experience with traditional antibody technology, while overcoming the limitations in the development and manufacture of bispecific antibodies.

Our experienced and proven team is well-positioned to leverage the strength of our proprietary bispecific antibody platform and to lead the advancement of Fcab-based antibodies to the clinic.

F-star funding secured through investors and strategic partnerships

To date F-star has raised more than €38 million in venture capital from VC investors: Aescap Venture, Atlas Venture, Novo Ventures, and TVM Capital; as well as from corporate investors: Merck Serono Ventures, MP Healthcare Venture Management, and SR One.

The company has two major alliances with Boehringer Ingelheim and Merck Serono, each covering multiple targets. The partnerships provide F-star with technology access fees, research funding, plus development and commercialization milestones, and royalties.

An asset-centric vehicle (“F-star Alpha Ltd.”) has been established to create greater commercial and financial flexibility for F-star, the investors, and future partners.

Location

Schwarzenbergplatz 7
Vienna
A-1030
Austria

Contact

Phone: 44 7881 244 040
Email: john.haurum@f-star.com


News Articles [299 Associated News Articles listed on BioPortfolio]

Amazing New Brain Map of Every Synapse Points to the Roots of Thinking

Imagine a map of every single star in an entire galaxy. A map so detailed that it lays out what each star looks like, what they’re made of, and how each star is connected to another through the gran...

Golden Star Announces Results of Special Meeting

TORONTO, Sept. 18, 2018 /PRNewswire/ - Golden Star Resources Ltd. (NYSE American: GSS; TSX: GSC; GSE: GSR) ("Golden Star" or the "Corporation") is pleased to Read more...

F-star, John Haurum, CEO:Designing and developing bispecific antibody products to improve the treatment of cancer.

In this episode of PharmaTelevision News Review, filmed at BIO Europe 2013, Vienna, Paul Larsmon speaks to John Haurum, CEO of F-star. They discuss the formation of the new asset centric vehicle, F-st...

Amid Protests from Hospitals, CMS Releases Overall Star Ratings

The overall quality star ratings are meant to help make informed healthcare decisions -- but are they accurate?

X-Ray Data May Be First Evidence of a Star Devouring a Planet

NewsNew data may explain star’s mysterious dimming.Contributed Author: Jennifer Chu,

What If Jackson Maine Had A Different Disease? - An Addiction Doctor's Take On 'A Star Is Born'

If alcohol and drug addiction weren't so severely stigmatized, the fictional music star - and countless others - would likely be alive today.

How to divide and conquer -F-star’s asset centric business model and their recent big deal with BMS.

F-star develops novel bispecific antibodies to improve the treatment of serious diseases, with a focus on immuno-oncology and inflammation. John Haurum explains to PharmaVentures' Adrian Dawkes how th...

A Young Star Caught Forming Like a Planet

NewsAstronomers have captured one of the most detailed views of a young star taken to date, and revealed an unexpected companion in orbit around it. Contributed Author: 

PubMed Articles [116 Associated PubMed Articles listed on BioPortfolio]

Drug carriers with star polymer structures.

In this review we summarize several synthetic approaches to the advanced synthesis of star-like polymer-based drug carriers. Moreover, their application as nanomedicines for therapy or the diagnosis o...

Pig StAR: mRNA expression and alternative splicing in testis and Leydig cells, and association analyses with testicular morphology traits.

Steroidogenic acute regulatory protein (StAR), primarily expressed in Leydig cells (LCs) in the mammalian testes, is essential for testosterone biosynthesis and male fertility. However, no previous re...

Rapid Neutrino Cooling in the Neutron Star MXB 1659-29.

We show that the neutron star in the transient system MXB 1659-29 has a core neutrino luminosity that substantially exceeds that of the modified Urca reactions (i.e., n+n→n+p+e^{-}+ν[over ¯]_{e} a...

E M (E=C-Pb, M=Li-Cs): A Source of Viable Star-Shaped Clusters.

Herein we report the systematic exploration of the potential energy surfaces of a series of clusters with formula E M (E=C-Pb and M=Li-Cs). Fifteen of these combinations adopt a D three-dimensional se...

Structural Studies of Three-Arm Star Block Copolymers Exposed to Extreme Stretch Suggests a Persistent Polymer Tube.

We present structural small-angle neutron scattering studies of a three-armed polystyrene star polymer with short deuterated segments at the end of each arm. We show that the form factor of the three-...

Clinical Trials [91 Associated Clinical Trials listed on BioPortfolio]

Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life

This study is being done to see if most patients are willing and able to report how they are feeling after surgery using the internet, and if this information can help doctors and nurses d...

Cognitive Aging - STAR

Cognitive outcomes in Co-STAR participants will be compared with those from participants in a parallel study of the effects of HT on cognitive outcomes, WHISCA. A comparison of the Co-STAR...

Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)

This study is being done to understand how survivors of head and neck cancer think they can make HN-STAR (the Survivor Self-Assessment, the survivorship clinic experience, and the Survivor...

ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe

The investigators will assess the usability and immune response following fractional dose inactivated polio virus vaccine (fIPV) administration with two novel intradermal adapters (ID adap...

Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced Wavescan Studio™ System and Star S4 IR™

Prospective, multicenter, bilaterally-treated, open-label, non-randomized clinical trial.

Companies [116 Associated Companies listed on BioPortfolio]

Five Star Quality Care, Inc.

Five Star Quality Care, Inc. is a senior living and healthcare services company. Five Star owns or leases and operates 217 senior living communities with 22,905 living units locat...

Five Star Senior Living, Inc.

Five Star Senior Living operates over 280 Independent Living, Assisted Living, Alzheimer’s/Memory Care, and Healthcare Centers with Skilled Nursing & Rehabilitation and Conti...

Five Star Senior Living

Five Star Senior Living is a national senior living and healthcare services provider proudly offering the highest quality service and care with the warmth and hospitality of home....

Five Star Senior Living Inc.

Five Star Senior Living Inc. is a senior living and healthcare services company. As of December 31, 2016, Five Star operated 283 senior living communities with 31,830 living un...

Star Food Healthy Express

Star Food Healthy Express is a division of VE South a leading vending machine company, based in Fort Lauderdale, Florida. Star Food Healthy Express is a concept that began more th...

More Information about "F-star" on BioPortfolio

We have published hundreds of F-star news stories on BioPortfolio along with dozens of F-star Clinical Trials and PubMed Articles about F-star for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of F-star Companies in our database. You can also find out about relevant F-star Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record